Cargando…

Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy

Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, and lipid–polymer hybrid nanoparticles—have received particular interest in antica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Ana Camila, Costa, Paulo C., Velho, Sérgia, Amaral, Maria Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864942/ https://www.ncbi.nlm.nih.gov/pubmed/36678845 http://dx.doi.org/10.3390/pharmaceutics15010216

Ejemplares similares

Injectable Poloxamer Hydrogels for Local Cancer Therapy
por: Marques, Ana Camila, et al.
Publicado: (2023)

Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
por: Bayón-Cordero, Laura, et al.
Publicado: (2019)

Stimuli-Responsive Hydrogels for Protein Delivery
por: Malta, Rafaela, et al.
Publicado: (2023)

Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain
por: Teixeira, Maria Inês, et al.
Publicado: (2022)

Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2019)

Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions
por: Marques-Magalhães, Ângela, et al.
Publicado: (2022)

Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023)

Remotely Activated Nanoparticles for Anticancer Therapy
por: Racca, Luisa, et al.
Publicado: (2020)

Effects of Steam Sterilization on the Properties of Stimuli-Responsive Polymer-Based Hydrogels
por: Ferreira, Inês, et al.
Publicado: (2023)

Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications
por: Wei, Qi-Yao, et al.
Publicado: (2019)

Silver Nanoparticles as Carriers of Anticancer Drugs for Efficient Target Treatment of Cancer Cells
por: Gomes, Helena I. O., et al.
Publicado: (2021)

Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
por: Wróblewska, Anna, et al.
Publicado: (2023)

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017)

Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?
por: Loh, Jian Sheng, et al.
Publicado: (2021)

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
por: Kim, Jeongrae, et al.
Publicado: (2023)

Dissecting the signaling pathways associated with the oncogenic activity of MLK3 P252H mutation
por: Velho, Sérgia, et al.
Publicado: (2014)

Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS
por: Dias Carvalho, Patrícia, et al.
Publicado: (2022)

Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2022)

Membrane-interactive lipids as experimental anticancer drugs.
por: Berdel, W. E.
Publicado: (1991)

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
por: Severino, Patrícia, et al.
Publicado: (2012)

Functionalized Graphene Platforms for Anticancer Drug Delivery
por: Sattari, Shabnam, et al.
Publicado: (2021)

Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers
por: Fernandes, Maria Sofia, et al.
Publicado: (2016)

Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy
por: Yeo, Sooho, et al.
Publicado: (2023)

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
por: Panebianco, Concetta, et al.
Publicado: (2018)

Lipid Metabolism and Resistance to Anticancer Treatment
por: Germain, Nicolas, et al.
Publicado: (2020)

Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
por: Ajith, Saniha, et al.
Publicado: (2023)

Pharmacogenetics of anticancer monoclonal antibodies
por: Shek, Dmitrii, et al.
Publicado: (2019)

Crosstalk between anticancer drugs and mitochondrial functions
por: Sahu, Kuleshwar, et al.
Publicado: (2021)

The Anticancer Drugs
por: Wilkinson, P.
Publicado: (1980)

Synthesis and Design of Purpurin-18-Loaded Solid Lipid Nanoparticles for Improved Anticancer Efficiency of Photodynamic Therapy
por: Yeo, Sooho, et al.
Publicado: (2022)

Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
por: Abdulbaqi, Ibrahim M., et al.
Publicado: (2021)

Bioconjugate-loaded solid lipid nanoparticles for enhanced anticancer drug delivery to brain cancer cells: An in vitro evaluation
por: Jain, Priyanka, et al.
Publicado: (2022)

Lipid-based nanoparticles for photosensitive drug delivery systems
por: Shim, Gayong, et al.
Publicado: (2022)

Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol
por: Zielińska, Aleksandra, et al.
Publicado: (2022)

Recent Advances and Challenges in Controlling the Spatiotemporal Release of Combinatorial Anticancer Drugs from Nanoparticles
por: Yoon, Moon Sup, et al.
Publicado: (2020)

Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery
por: Jurczyk, Magdalena, et al.
Publicado: (2021)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Solid Lipid Nanoparticles of Curcumin Designed for Enhanced Bioavailability and Anticancer Efficiency
por: Yeo, Sooho, et al.
Publicado: (2022)

Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan–Fucoidan Nanoparticles
por: Choi, Dae Gun, et al.
Publicado: (2019)

Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells
por: Shen, Yuzhou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_13bikavjngo5vntbe9bjh6d1o6